Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Lantheus Holdings Inc (Lantheus) carries out the development, manufacturing, sale and distribution of diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The company offers products such as DEFINITY, VIALMIX, TechneLite, Xenon-133, NEUROLITE, Cardiolite, Gallium-68, and ABLAVAR. It offers its products in the therapeutic area of oncology, urology, nuclear medicine, cardiology, sonography and radiology among others. The company serves to hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacy, clinics and group practices. The company distributes its products in Europe, Asia, Asia-Pacific, Central America and South America. Lantheus is headquartered in Bedford, Massachusetts, the US.
Headquarters
United States of America
Address
331 Treble Cove Rd, North Billerica, Massachusetts, 01862
Website
www.lantheus.com
Telephone
1 978 6718001
No of Employees
834
Industry
Medical Equipment
Ticker Symbol & Exchange
LNTH (NASD)
Revenue (2022)
$1.3B
38.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
1063.9%
(2022 vs 2021)
Market Cap*
$5.3B
Net Profit Margin (2022)
XYZ
740.0%
(2022 vs 2021)
* As of and is in US$
Lantheus Holdings Inc premium industry data and analytics
Products and Services
| Products |
|---|
| DEFINITY |
| VIALMIX |
| TechneLite |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In August, the company announced the divestiture of its RELISTOR (methylnaltrexone bromide) net sales royalties. |
| 2023 | Acquisitions/Mergers/Takeovers | In February, the company acquired Cerveau Technologies. |
| 2022 | Contracts/Agreements | In November, the company entered into an agreement with POINT Biopharma Global under which Lantheus will license exclusive worldwide rights1 to POINT’s PNT2002 and PNT2003 product candidates. |
Competitor Comparison
| Key Parameters | Lantheus Holdings Inc | GE HealthCare Technologies Inc | Hologic Inc | Seagen Inc | Fonar Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | North Billerica | Chicago | Marlborough | Bothell | Melville |
| State/Province | Massachusetts | Illinois | Massachusetts | Washington | New York |
| No. of Employees | 834 | 51,000 | 6,990 | 3,256 | 561 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mary Anne Heino | President; Chief Executive Officer; Director | Executive Board | 2015 | 63 |
| Robert J. Marshall Jr. | Treasurer; Chief Financial Officer | Senior Management | 2018 | 56 |
| Andrea Sabens | Chief Accounting Officer | Senior Management | - | - |
| Dan Niedzwiecki | Chief Administrative Officer | Senior Management | 2023 | - |
| Jean-Claude Provost | Chief Medical Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer